AMRI has entered into several development and supply agreements with Genovi Pharmaceuticals to manufacture select generic parenteral drug products for registration and subsequent commercialization in the U.S., Europe, and select emerging markets.   AMRI will provide cGMP manufacture and analytical support for the registration of five product candidates, and will be reimbursed for technology transfer, analytical development and manufacture of regulatory submission batches. AMRI is also eligible t...